BridgeBio Pharma, Inc (BBIO) insider trading
Every open-market stock purchase and sale by BridgeBio Pharma, Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.
Insider activity at a glance
- Neil Kumar (CEO) and 1 other sold $4.6M in the last 90 days.
- Last insider buy: Andrea Ellis (Director), $101K, 4 years ago.
- Congress: Gilbert Cisneros sold $1K to $15K, 3 weeks ago.
Last 12 months: insiders bought $0 (0 buys) and sold $114M (38 sales). Last close $67.74 on Oct 21, 2026.
Recent BBIO insider trades
| Date | Insider | Trade | Value |
|---|---|---|---|
| Sep 29, 2026 | Gilbert Cisneros (Representative) | Sold | $1K–15K |
| Sep 17, 2026 | Neil Kumar (CEO) | Sold | $602K |
| Sep 17, 2026 | Neil Kumar (CEO) | Sold | $89K |
| Aug 19, 2026 | Neil Kumar (CEO) | Sold | $679K |
| Aug 19, 2026 | Neil Kumar (CEO) | Sold | $152K |
| Aug 19, 2026 | Neil Kumar (CEO) | Sold | $8.6K |
| Aug 18, 2026 | Neil Kumar (CEO) | Sold | $1.4M |
| Aug 18, 2026 | Neil Kumar (CEO) | Sold | $1.2M |
| Aug 18, 2026 | Neil Kumar (CEO) | Sold | $154K |
| Aug 18, 2026 | Neil Kumar (CEO) | Sold | $100K |
| Aug 16, 2026 | Neil Kumar (CEO) | Sold (not open market) | $2.9M |
| Aug 16, 2026 | Thomas Trimarchi (CFO) | Sold (not open market) | $1.8M |
| Aug 16, 2026 | Maricel Apuli (C-suite exec) | Sold (not open market) | $376K |
| Aug 16, 2026 | Neil Kumar (CEO) | Bought (not open market) | — |
| Aug 16, 2026 | Neil Kumar (CEO) | Bought (not open market) | — |
| Aug 16, 2026 | Neil Kumar (CEO) | Bought (not open market) | — |
| Aug 16, 2026 | Neil Kumar (CEO) | Bought (not open market) | — |
| Aug 16, 2026 | Neil Kumar (CEO) | Bought (not open market) | — |
| Aug 16, 2026 | Neil Kumar (CEO) | Bought (not open market) | — |
| Aug 16, 2026 | Neil Kumar (CEO) | Bought (not open market) | — |
| Aug 16, 2026 | Neil Kumar (CEO) | Bought (not open market) | — |
| Jul 30, 2026 | Maricel Apuli (C-suite exec) | Sold | $160K |
| Jul 9, 2026 | Jennifer E. Cook (Director) | Sold | $10.1M |
| Jul 9, 2026 | Jennifer E. Cook (Director) | Bought (not open market) | $3.3M |
| Jul 9, 2026 | Jennifer E. Cook (Director) | Sold | $3M |
Who's trading BBIO
- Gilbert Cisneros, Representative: bought $40K (5 buys), sold $8K (1 sale), last Sep 29, 2026
- Neil Kumar, CEO: sold $52.7M (103 sales), last Sep 17, 2026
- Maricel Apuli, C-suite exec: sold $622K (5 sales), last Aug 16, 2026
- Thomas Trimarchi, CFO: sold $3M (6 sales), last Aug 16, 2026
- Jennifer E. Cook, Director: sold $21.9M (6 sales), last Jul 9, 2026
- Andrea Ellis, Insider: sold $5.7M (2 sales), last Jul 9, 2026
- Hannah Valantine, Director: sold $4.4M (6 sales), last Jun 23, 2026
- Eric Aguiar, Insider: other filings, last Jun 22, 2026
- Fred Hassan, Insider: other filings, last Jun 22, 2026
- James C Momtazee, Insider: other filings, last Jun 22, 2026
- Ali J. Satvat, Insider: other filings, last Jun 22, 2026
- Ronald J Daniels, Director: sold $3.9M (1 sale), last Jun 22, 2026
- Charles J Homcy, Insider: other filings, last Jun 22, 2026
- Douglas A. Dachille, Insider: other filings, last Jun 22, 2026
- Andrew Lo, Director: sold $6.3M (4 sales), last Jun 22, 2026
Get free alerts when an insider at BridgeBio Pharma, Inc files a new trade →